/
ABDXF
$0.14+$0.01 (+11.07%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.12 – $0.21
16% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change+$0.07
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M | $2.3M | $5.2M | $11.6M | $2.8M | $4.0M | $6.1M | $8.4M |
| Cost of revenue | $924.6K | $844.5K | $1.2M | $8.2M | $8.1M | $2.0M | $2.5M | $4.7M |
| Gross profit | $1.3M | $1.4M | $4.1M | $3.4M | −$5.2M | $2.1M | $3.7M | $3.7M |
| Gross margin | 59.2% | 62.9% | 77.5% | 29.2% | -184.4% | 51.3% | 60.0% | 44.3% |
| R&D | $285.0K | $210.7K | $854.0K | $503.0K | $182.0K | $0 | $0 | $0 |
| Operating income | −$4.7M | −$1.5M | $91.7K | −$5.5M | −$12.1M | −$3.6M | −$1.4M | −$3.5M |
| EBITDA | −$4.0M | −$1.1M | $810.0K | −$4.8M | −$19.9M | −$3.2M | −$916.0K | −$2.8M |
| Net income | $3.5M | −$1.3M | −$3.4M | −$7.0M | −$21.3M | −$3.5M | −$1.3M | −$3.4M |
| Net margin | 152.9% | -55.3% | -64.4% | -60.0% | -750.0% | -85.8% | -20.7% | -40.5% |
| EPS (diluted) | 0.04 | -0.01 | -0.04 | -0.07 | -0.07 | -0.01 | -0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $12M | $-0.00 | $-0.00–$-0.00 | 1 |
| 2027 | $15M | $0.00 | $0.00–$0.00 | 1 |
| 2028 | $17M | $0.00 | $0.00–$0.00 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
ABINGDON HEALTH PLC
ABINGDON HEALTH PLC
Held by traders on TradeandTell
No one on the platform currently holds ABDXF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ABDXF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ABDXF yet.